338 related articles for article (PubMed ID: 29416776)
21. Rhabdomyolysis and Acute Renal Dysfunction as Initial Manifestations of Monoclonal Gammopathy of Renal Significance.
Gudapati P; Al-Sultani A; Parmar A; Motwani R; Fortkort P
Cureus; 2023 Feb; 15(2):e34759. PubMed ID: 36909104
[TBL] [Abstract][Full Text] [Related]
22. Post-MGUS Diagnosis Serum Monoclonal-Protein Velocity and the Progression of Monoclonal Gammopathy of Undetermined Significance to Multiple Myeloma.
Chang SH; Gumbel J; Luo S; Thomas TS; Sanfilippo KM; Luo J; Colditz GA; Carson KR
Cancer Epidemiol Biomarkers Prev; 2019 Dec; 28(12):2055-2061. PubMed ID: 31501149
[TBL] [Abstract][Full Text] [Related]
23. Monoclonal gammopathy: The good, the bad and the ugly.
Glavey SV; Leung N
Blood Rev; 2016 May; 30(3):223-31. PubMed ID: 26732417
[TBL] [Abstract][Full Text] [Related]
24. Direct infiltration of clonal plasma cells causes renal insufficiency in patients with monoclonal gammopathy of undetermined significance.
Naka R; Shimomura Y; Kanda-Kato M; Hiramoto N; Hara S; Ishikawa T
EJHaem; 2023 Aug; 4(3):829-832. PubMed ID: 37601873
[TBL] [Abstract][Full Text] [Related]
25. Association between metformin use and progression of monoclonal gammopathy of undetermined significance to multiple myeloma in US veterans with diabetes mellitus: a population-based retrospective cohort study.
Chang SH; Luo S; O'Brian KK; Thomas TS; Colditz GA; Carlsson NP; Carson KR
Lancet Haematol; 2015 Jan; 2(1):e30-6. PubMed ID: 26034780
[TBL] [Abstract][Full Text] [Related]
26. Nephrotic syndrome secondary to amyloidosis in a patient with monoclonal gammopathy with renal significance (MGRS).
Niculae A; Peride I; Vinereanu V; Rădulescu D; Bratu OG; Geavlete BF; ChecheriŢă IA
Rom J Morphol Embryol; 2017; 58(3):1065-1068. PubMed ID: 29250691
[TBL] [Abstract][Full Text] [Related]
27. Long-term follow-up of patients with monoclonal gammopathy of undetermined significance after kidney transplantation.
Naina HV; Harris S; Dispenzieri A; Cosio FG; Habermann TM; Stegall MD; Dean PG; Prieto M; Kyle RA; Rajkumar SV; Leung N
Am J Nephrol; 2012; 35(4):365-71. PubMed ID: 22473253
[TBL] [Abstract][Full Text] [Related]
28. Kidney Histopathologic Spectrum and Clinical Indicators Associated with MGRS.
Yong ZH; Yu XJ; Liu JX; Zhou FD; Wang SX; Zhao MH
Clin J Am Soc Nephrol; 2022 Apr; 17(4):527-534. PubMed ID: 35210280
[TBL] [Abstract][Full Text] [Related]
29. The Role of Diagnosis and Clinical Follow-up of Monoclonal Gammopathy of Undetermined Significance on Survival in Multiple Myeloma.
Sigurdardottir EE; Turesson I; Lund SH; Lindqvist EK; Mailankody S; Korde N; Björkholm M; Landgren O; Kristinsson SY
JAMA Oncol; 2015 May; 1(2):168-74. PubMed ID: 26181017
[TBL] [Abstract][Full Text] [Related]
30. [Clinical characteristics and progression risk factors for patients with monoclonal gammopathy of undetermined significance].
Guan A; Shen KN; Zhang L; Cao XX; Su W; Zhou DB; Li J
Zhonghua Xue Ye Xue Za Zhi; 2023 Feb; 44(2):137-140. PubMed ID: 36948868
[No Abstract] [Full Text] [Related]
31. [Clinical Significance of Serum Free Light Chain in Monoclonal Gammopathy].
Lu H; Zhang W
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2024 Feb; 32(1):155-158. PubMed ID: 38387914
[TBL] [Abstract][Full Text] [Related]
32. Monoclonal Gammopathy of Undetermined Significance (MGUS)-Not So Asymptomatic after All.
Lomas OC; Mouhieddine TH; Tahri S; Ghobrial IM
Cancers (Basel); 2020 Jun; 12(6):. PubMed ID: 32545521
[TBL] [Abstract][Full Text] [Related]
33. Long-Term Follow-up of Monoclonal Gammopathy of Undetermined Significance.
Kyle RA; Larson DR; Therneau TM; Dispenzieri A; Kumar S; Cerhan JR; Rajkumar SV
N Engl J Med; 2018 Jan; 378(3):241-249. PubMed ID: 29342381
[TBL] [Abstract][Full Text] [Related]
34. Light chain Fanconi syndrome in a patient with acute myeloid leukemia and monoclonal gammopathy of undetermined significance.
Ross DW; Wanchoo R; Guigova A; Ghiuzeli C; Allen SL; Jhaveri KD
CEN Case Rep; 2016 Nov; 5(2):238-241. PubMed ID: 28508985
[TBL] [Abstract][Full Text] [Related]
35. Laboratory and clinical characterization of monoclonal gammopathy in Taiwanese.
Lee LN; Jan IS; Tien HF; Lin JS; Lo SC; Cheng WC
J Formos Med Assoc; 2002 Feb; 101(2):91-7. PubMed ID: 12099210
[TBL] [Abstract][Full Text] [Related]
36. Prognosis of young patients with monoclonal gammopathy of undetermined significance (MGUS).
Pang L; Rajkumar SV; Kapoor P; Buadi F; Dispenzieri A; Gertz M; Lacy M; Kyle R; Kumar S
Blood Cancer J; 2021 Feb; 11(2):26. PubMed ID: 33563898
[TBL] [Abstract][Full Text] [Related]
37. Monoclonal Gammopathy of Renal Significance (MGRS): Prospects for Treatment in Integrated Chinese and Western Medicine.
Li JP; Du YT; Li S; Rao XR
Chin J Integr Med; 2021 Sep; 27(9):643-648. PubMed ID: 34105098
[TBL] [Abstract][Full Text] [Related]
38. Progression patterns in monoclonal gammopathy of undetermined significance and multiple myeloma outcome: a cohort study in 42 patients.
Tahiru W; Izarra Santamaria A; Hultdin J; Wu WY; Späth F
Exp Hematol Oncol; 2022 Feb; 11(1):8. PubMed ID: 35197127
[TBL] [Abstract][Full Text] [Related]
39. The prevalence and significance of monoclonal gammopathy of undetermined significance in acute medical admissions.
Atkin C; Reddy-Kolanu V; Drayson MT; Sapey E; Richter AG
Br J Haematol; 2020 Jun; 189(6):1127-1135. PubMed ID: 31999849
[TBL] [Abstract][Full Text] [Related]
40. [Monoclonal gammopathy of undetermined significance--potential risk factor of multiple myeloma].
Stelmach-Gołdyś A; Czarkowska-Paczek B
Przegl Lek; 2012; 69(5):194-6. PubMed ID: 23050415
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]